Prevalence of depression and depressive symptoms among patients using beta-blockers in King Khalid University Hospital, Riyadh Saudi Arabia: A cross-sectional study

Background: The relationship between depression and beta-blockers (BBs) use is a controversial topic for many decades. Due to the interference with adrenergic and serotonin receptors, BB use has been linked to depression in many early cross-sectional and case studies. Others have investigated the in...

Full description

Bibliographic Details
Main Authors: Mohammed A Al-Jaffer, Ibrahim Bader Al-Shaqrawi, Omar H Al-Omar, Abdullah A Al-Jammaz, Meshaal K Al-Ghanim, Albaraa M Al-Saif, Mohammed N Al-Shunayf
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Journal of Nature and Science of Medicine
Subjects:
Online Access:http://www.jnsmonline.org/article.asp?issn=2589-627X;year=2023;volume=6;issue=1;spage=46;epage=50;aulast=Al-Jaffer
_version_ 1797904790369337344
author Mohammed A Al-Jaffer
Ibrahim Bader Al-Shaqrawi
Omar H Al-Omar
Abdullah A Al-Jammaz
Meshaal K Al-Ghanim
Albaraa M Al-Saif
Mohammed N Al-Shunayf
author_facet Mohammed A Al-Jaffer
Ibrahim Bader Al-Shaqrawi
Omar H Al-Omar
Abdullah A Al-Jammaz
Meshaal K Al-Ghanim
Albaraa M Al-Saif
Mohammed N Al-Shunayf
author_sort Mohammed A Al-Jaffer
collection DOAJ
description Background: The relationship between depression and beta-blockers (BBs) use is a controversial topic for many decades. Due to the interference with adrenergic and serotonin receptors, BB use has been linked to depression in many early cross-sectional and case studies. Others have investigated the indirect relationship between BB use and novice antidepressant use. However, larger trials have yielded inconsistent findings. The objective of this study is to identify the presence of depression and depressive symptoms among patients using BBs in the internal medicine, cardiology, and psychiatry Departments in King Khalid University Hospital (KKUH) and to measure its prevalence. Research Design and Methods: A cross-sectional study included patients visiting Internal Medicine, Cardiology, and Psychiatry clinics at the KKUH in Riyadh, Saudi Arabia, who is known using BBs for any indication and excluded patients previously diagnosed with depression before taking BBs. This study was carried out from December 2018 to October 2019. Either physically or over the phone, patients were requested to complete the Patient Health Questionnaire-9 questionnaire. Drug names and pictures were provided for ease of drug identification. The sample size was 291, with a confidence interval of 95% and 5% margin of error. Written consent was acquired from all participants. Results: Two hundred and ninety-one surveys were collected, among 151 (52%) were females and 140 (48%) were males. Females were more likely to report depressive symptoms and had higher scores of symptom severity on average (P < 0.016). Only 17 patients (5.8%) were found to report no depressive symptoms, while most patients reported mild depressive symptoms (35%). We have not found a statistically significant relationship between BB type and the magnitude of depressive symptoms severity. Conclusions: Although the usage of BBs and the prevalence of depressive symptoms were not directly correlated in our study, compared to the local prevalence, our patients demonstrated a higher prevalence trend of depressed symptoms. In addition, our observations did reveal fascinating information on the gender disparity in depression.
first_indexed 2024-04-10T09:54:30Z
format Article
id doaj.art-a223be18b3ad44268725c0e1f4e4026b
institution Directory Open Access Journal
issn 2589-627X
2589-6288
language English
last_indexed 2024-04-10T09:54:30Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Nature and Science of Medicine
spelling doaj.art-a223be18b3ad44268725c0e1f4e4026b2023-02-16T12:42:08ZengWolters Kluwer Medknow PublicationsJournal of Nature and Science of Medicine2589-627X2589-62882023-01-0161465010.4103/jnsm.jnsm_59_22Prevalence of depression and depressive symptoms among patients using beta-blockers in King Khalid University Hospital, Riyadh Saudi Arabia: A cross-sectional studyMohammed A Al-JafferIbrahim Bader Al-ShaqrawiOmar H Al-OmarAbdullah A Al-JammazMeshaal K Al-GhanimAlbaraa M Al-SaifMohammed N Al-ShunayfBackground: The relationship between depression and beta-blockers (BBs) use is a controversial topic for many decades. Due to the interference with adrenergic and serotonin receptors, BB use has been linked to depression in many early cross-sectional and case studies. Others have investigated the indirect relationship between BB use and novice antidepressant use. However, larger trials have yielded inconsistent findings. The objective of this study is to identify the presence of depression and depressive symptoms among patients using BBs in the internal medicine, cardiology, and psychiatry Departments in King Khalid University Hospital (KKUH) and to measure its prevalence. Research Design and Methods: A cross-sectional study included patients visiting Internal Medicine, Cardiology, and Psychiatry clinics at the KKUH in Riyadh, Saudi Arabia, who is known using BBs for any indication and excluded patients previously diagnosed with depression before taking BBs. This study was carried out from December 2018 to October 2019. Either physically or over the phone, patients were requested to complete the Patient Health Questionnaire-9 questionnaire. Drug names and pictures were provided for ease of drug identification. The sample size was 291, with a confidence interval of 95% and 5% margin of error. Written consent was acquired from all participants. Results: Two hundred and ninety-one surveys were collected, among 151 (52%) were females and 140 (48%) were males. Females were more likely to report depressive symptoms and had higher scores of symptom severity on average (P < 0.016). Only 17 patients (5.8%) were found to report no depressive symptoms, while most patients reported mild depressive symptoms (35%). We have not found a statistically significant relationship between BB type and the magnitude of depressive symptoms severity. Conclusions: Although the usage of BBs and the prevalence of depressive symptoms were not directly correlated in our study, compared to the local prevalence, our patients demonstrated a higher prevalence trend of depressed symptoms. In addition, our observations did reveal fascinating information on the gender disparity in depression.http://www.jnsmonline.org/article.asp?issn=2589-627X;year=2023;volume=6;issue=1;spage=46;epage=50;aulast=Al-Jafferbeta-blockersdepressionpatient health questionnaire-9
spellingShingle Mohammed A Al-Jaffer
Ibrahim Bader Al-Shaqrawi
Omar H Al-Omar
Abdullah A Al-Jammaz
Meshaal K Al-Ghanim
Albaraa M Al-Saif
Mohammed N Al-Shunayf
Prevalence of depression and depressive symptoms among patients using beta-blockers in King Khalid University Hospital, Riyadh Saudi Arabia: A cross-sectional study
Journal of Nature and Science of Medicine
beta-blockers
depression
patient health questionnaire-9
title Prevalence of depression and depressive symptoms among patients using beta-blockers in King Khalid University Hospital, Riyadh Saudi Arabia: A cross-sectional study
title_full Prevalence of depression and depressive symptoms among patients using beta-blockers in King Khalid University Hospital, Riyadh Saudi Arabia: A cross-sectional study
title_fullStr Prevalence of depression and depressive symptoms among patients using beta-blockers in King Khalid University Hospital, Riyadh Saudi Arabia: A cross-sectional study
title_full_unstemmed Prevalence of depression and depressive symptoms among patients using beta-blockers in King Khalid University Hospital, Riyadh Saudi Arabia: A cross-sectional study
title_short Prevalence of depression and depressive symptoms among patients using beta-blockers in King Khalid University Hospital, Riyadh Saudi Arabia: A cross-sectional study
title_sort prevalence of depression and depressive symptoms among patients using beta blockers in king khalid university hospital riyadh saudi arabia a cross sectional study
topic beta-blockers
depression
patient health questionnaire-9
url http://www.jnsmonline.org/article.asp?issn=2589-627X;year=2023;volume=6;issue=1;spage=46;epage=50;aulast=Al-Jaffer
work_keys_str_mv AT mohammedaaljaffer prevalenceofdepressionanddepressivesymptomsamongpatientsusingbetablockersinkingkhaliduniversityhospitalriyadhsaudiarabiaacrosssectionalstudy
AT ibrahimbaderalshaqrawi prevalenceofdepressionanddepressivesymptomsamongpatientsusingbetablockersinkingkhaliduniversityhospitalriyadhsaudiarabiaacrosssectionalstudy
AT omarhalomar prevalenceofdepressionanddepressivesymptomsamongpatientsusingbetablockersinkingkhaliduniversityhospitalriyadhsaudiarabiaacrosssectionalstudy
AT abdullahaaljammaz prevalenceofdepressionanddepressivesymptomsamongpatientsusingbetablockersinkingkhaliduniversityhospitalriyadhsaudiarabiaacrosssectionalstudy
AT meshaalkalghanim prevalenceofdepressionanddepressivesymptomsamongpatientsusingbetablockersinkingkhaliduniversityhospitalriyadhsaudiarabiaacrosssectionalstudy
AT albaraamalsaif prevalenceofdepressionanddepressivesymptomsamongpatientsusingbetablockersinkingkhaliduniversityhospitalriyadhsaudiarabiaacrosssectionalstudy
AT mohammednalshunayf prevalenceofdepressionanddepressivesymptomsamongpatientsusingbetablockersinkingkhaliduniversityhospitalriyadhsaudiarabiaacrosssectionalstudy